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The thermal decarboxylation of N-benzyloxycar- 
bonyl-L-7-carboxyglutamic acid  a-methyl  ester ((2)-L- 
Gla-OMe) has  been  studied.  In  the  presence  of  increas- 
ing amounts  of  calcium  or  magnesium  ions,  lyophilized 
powders  of  (Z)-L-Gla-OMe exhibit a corresponding  in- 
crease  in  thermal stability. Both  magnesium  and cal- 
cium  form relatively tight, thermally  stable  complexes 
with (2)-L-Gla-OMe at high  metal  ion  concentrations. 
Differences between Ca(I1) and Mg(I1) binding are 
noted at low metal ion concentrations, where (2)-L- 
Gla-OMe is in excess. Under  these  conditions,  complex 
formation with Mg(I1) apparently favors a 2:l Gla- 
magnesium  ion  complex  in  which  both  Gla  residues  are 
unstable to thermal  decarboxylation.  Calcium  ion  com- 
plexes, however, are found  to favor a 3:l Gla-calcium 
ion  complex  in  which 1 of  the 3 Gla residues is ther- 
mally  stable. 
The metal ion-binding ability of several coagulation pro- 
teins  (Factors 11, VII, IX,  and  X  and  proteins C, s, and Z) 
likely resides in the properties of a unique amino acid, y- 
carboxyglutamic acid (Gla).’ Gla is formed in  a  post-transla- 
tional, vitamin K-mediated carboxylation of specific glutamyl 
residues in  the  intact protein (1-4). The coagulation cascade 
can be best summarized as a series of cleavages of a zymogen 
(usually Gla-containing) to  an activated enzyme by an enzyme 
complex consisting of the appropriate enzyme (serine pro- 
tease, usually Gla-containing), coenzyme (organizing protein), 
and an acidic phospholipid surface (5). Both the assembly and 
activity of the enzyme complex requires the presence of Ca(I1) 
(6). It has been observed that  other metal ions (e.g. Mg(II), 
Mn(II), Tb(III), Gd(III), and Eu(II1)) cannot support the 
blood coagulation cascade at  physiologically important rates. 
The differentiation between the activity of the Ca(I1) and 
Mg(I1) ion-laden, Gla-containing protein is striking since both 
divalent metal ions are at similar concentrations in blood 
(Mg(II), 0.9 mM; Ca(II), 2.4 mM) (7).  Metal ion equilibrium 
dialysis of bovine prothrombin fragment 1 indicates there  are 
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approximately seven Ca(I1) ions bound per protein molecule 
and  the Scatchard plot shows substantial cooperativity (8). 
The Scatchard  plot for the Mg(1I) ion equilibrium dialysis, 
however, indicates there  are approximately five ions bound 
per protein molecule and these ions are bound in essentially 
equivalent, noninteracting  sites (9). Furthermore, prothrom- 
bin fragment 1 will bind to phosphatidylserine-phosphatidyl- 
choline vesicle surfaces in the presence of Ca(I1) ions, but not 
in  the presence of Mg(I1) ions (3). Although the molecular 
basis of this differentiation between the interaction of these 
divalent metal ions and Gla-containing proteins has  not been 
fully delineated, it is known that the protein’s metal ion 
binding affinity is associated with the malonate subunit of 
the Gla  residues. 
Thermal decarboxylation has been used in the study of 
carboxylate ion-metal ion interactions in Gla-containing pro- 
teins (10, 11). A report by Poser and Price (12) documented 
that osteocalcin (“Bone Gla Protein”) is completely decarbox- 
ylated by heating a sample obtained by lyophilization from 
0.05 M HC1 buffer. Rate studies at several different pH values 
suggest that a  proton source is necessary for decarboxylation. 
Similarly, acid hydrolysis leads to decarboxylation but base 
hydrolysis does not (13-15). Poser and Price have also shown 
that ammonium salts will function as the proton source for 
Gla and  that these carboxylate-ammonium salts will decar- 
boxylate at a  rate comparable to  the protonated carboxylic 
acid. A recent study (16) reported the decarboxylation of N-  
benzyloxycarbonyl-y-carboxyglutamic acid a-methyl  ester 
((2)-Gla-OMe) in the presence of guanidine. This study found 
that the 1:1 (2)-Gla-OMe-guanidine complex would decar- 
boxylate, whereas the 1:2 complex  was “protected.” 
Any interaction which leads to displacement of protons (or 
ammonium ions), such as occurs in the binding of Na(I), 
Ca(II), or Mg(I1) ions, will “protect”  the y-carboxyl groups 
from decarboxylation; for example, the disodium salt of Gla 
is thermally stable. “Protection” in this sense refers to  the 
attenuation of decarboxylation by electrostatic and/or steric 
interactions. Poser and Price (12), for instance, noted that 
osteocalcin remained unchanged after 4 h at 110 “C when 
bound to hydroxylapatite. Similarly, Bajaj et al. (17) studied 
the interaction of Ca(I1) ions with human prothrombin by 
thermal decarboxylation. Protein samples lyophilized from 
buffers containing Ca(I1) ions showed a corresponding in- 
crease in Gla protection, resulting in a “protection profile.” 
Bajaj et al. (17) inferred that  the binding of two Ca(I1) ions 
to human prothrombin protected 6 Gla residues from decar- 
boxylation. 
An important question emerges: How does a metal ion 
interact with a  substituted malonic acid to prevent decarbox- 
ylation? Although it  is apparent from the studies of Bajaj et 
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al. (17)  and  Poser  and  Price (12) that  the Ca(I1) ion-laden 
protein Gla residues  are  protected  from  thermal decarboxyl- 
ation, it is  not obvious on a molecular level as to  the  mecha- 
nism of this Ca(I1) ion-dependent protection. The stoichi- 
ometry of the Ca(I1) ion/Gla residue complex in  the  intact 
protein  is difficult to ascertain because of the possibility of 
interactions of Gla  residues  with  cations  other  than  Ca(II), 
such as the  formation of salt bridges with  arginine  or lysine 
residues. In  the  present work the differences in  the  binding 
of Ca(I1) and Mg(I1) ions  with Gla were studied by thermal 
decarboxylation of lyophilized  powders obtained  from  peptide 
and  metal  ion solutions. 
EXPERIMENTAL PROCEDURES 
General  Methods and Amino Acid Analysis-The preparation of 
(2)-L-Gla-OMe has been previously described (18-20). All other 
chemicals are commercially  available and were  not  purified prior to 
use. The concentrations of the aqueous  solutions  containing  metal 
ions  were determined by atomic  absorption  spectrophotometry  on a 
Perkin-Elmer 560 AA spectrophotometer. Using an adaptation of the 
analytical  method of Klapper (21), high  performance  liquid  chroma- 
tography  for  amino  acid  analysis was performed at 63 "C on a water- 
jacketed Bio-Rad Aminex A-9 column (4 mm X 25 cm) (Bio-Rad) 
using  2-propanol (2%, v/v) in  sodium citrate (0.1 M, pH  3.25) as the 
eluent.  Detection of amino  acids  was  accomplished  by the use of a 
fluorometric  reagent,  o-phthaldehyde  (325  mg/liter,  pH  10.40)  with 
Brij-35@ (3 ml/liter, Pierce Chemical Co.) as a surfactant. Fluores- 
cence was measured at 455 nm after excitation at 360 nm. With a 
flow rate of 0.5 ml/min  buffer  (0.4  ml/min  fluorometric  reagent), y- 
carboxyglutamic  acid  elutes at 11.5  min. The extent of decarboxyla- 
tion was determined by the reduction in y-carboxyglutamic  acid  and 
the corresponding  increase  in  glutamic  acid  in the alkaline  hydroly- 
sates of the heated  peptide/metal  ion  samples. 
Decarboxylation of (2)-L-Gla-OMe in the Presence of Ca(ZZ) and 
Mg(ZZ)-An appropriate  amount of a solution  containing the metal 
ion (approximately 25 mM as determined by  atomic absorption) was 
added to an ammonium  bicarbonate  buffered  (0.1 M,pH  7.85)  solution 
of (2)-L-Gla-OMe (1.00 ml, either 0.212, 2.12, or 17.5 mM). The 
equilibrium  mixtures  were  frozen and lyophilized  in  polypropylene- 
lined glass reaction tubes, and the resulting powder was heated at 
110 "C  for 1 h in uacuo. After  heating, the samples  were  hydrolyzed 
by  dissolving the powder in sodium  hydroxide  solution (2 N, 1.00 ml) 
and heating  in uacuo for 24 h at 110 "C. The samples  were titrated to 
a pH of 2.2 with HC1 (1 N), and the Gla/Glu ratio was determined  as 
above. 
RESULTS 
The fractional  protection of (2)-L-Gla-OMe  (percent  Gla 
remaining  in  the lyophilized powder after heating at 110 "C 
for 1 h) as a function of the  metal  ion/peptide  ratio for  Ca(I1) 
and Mg(I1) is given in Figs. 1 and 2, respectively. Three 
different  initial  concentrations of (2)-L-Gla-OMe were inves- 
tigated 0.2, 2.1, and 17.5 mM. The metal  ion  concentration 
was adjusted to  give the  appropriate  molar  ratio of metal to 
peptide  (molar ratios: 0, 1:8, 1:4, 1:3, 1:2, 3:4, 1, 2, 4, and 8). 
Each data point represents the average of three separate 
experiments; for each experiment, duplicate determinations 
of the  percent  Gla were performed. The  standard  deviation 
for each Ca(I1) ion and Mg(I1) ion data point was 1.0 and 
1.3% absolute  error, respectively. 
The tlh for  the  decarboxylation of a lyophilized sample of 
the  ammonium  salt of (2)-L-Gla-OMe was found  to  be 0.23 h 
(5" = 110 "C) (Fig. 3). Under  the  same  conditions,  the tH for 
the powder obtained  from  the lyophilization of a solution of 
2.0 mM peptide  and 8.0 mM calcium was  significantly  greater 
than 1 day. Since significant differences were observed be- 
tween the curves obtained at different  peptide  concentrations 
(Figs. 1 and  2), it was  concluded that  the  peptide  and  metal 
did  not  rearrange  during lyophilization. 
Experimental data was analyzed by computational  simula- 
tion using four reasonable equilibrium models. During  this 
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FIG. 1. Thermal  decarboxylation of (2)-L-Gla-OMe in  the 
presence of Ca(I1). Peptide  samples at various  concentrations (A, 
0.2 mM; ., 2 mM; 0, 17 mM) were lyophilized from ammonium 
bicarbonate  buffer  (0.1 M) containingvarious  concentrations of Ca(I1) 
ions, sealed, and heated in u a c w  at 110 "C for 1 h. Percent Gla 
remaining  is  presented  as a function of peptide/calcium  ratio  present 
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FIG. 2. Thermal  decarboxylation of (2)-L-Gla-OMe in  the 
presence of Mg(I1).  Peptide  samples at various  concentrations (A, 
0.2  mM; ., 2 mM; 0, 17 mM) were lyophilized from ammonium 
bicarbonate  buffer  (0.1 M) containing  various  concentrations of 
Mg(I1)  ions,  sealed, and heated  in vacuo at 110 'C for 1 h. Percent 
Gla  remaining is  presented as a function of peptide/magnesium  ratio 
present  prior to lyophilization. 
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FIG. 3. Semilogarithmic plot of percent Gla remaining uer- 
sua duration of heating at 110 'C for (2)-L-Gla-OMe. Samples 
of (2)-L-Gla-OMe (2.5 mM)  were  lyophilized  from  ammonium bicar- 
bonate  (0.1 M) and  heated  in uacuo. 
process,  two criteria were employed for  the  evaluation of a 
specific model: 1) how well the individual protection profiles 
were modeled by the calculated parameters,  and 2) how con- 
sistently  the equilibrium constants were reproduced  for the 
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FIG. 4. Thermal decarboxylation of (2)-L-Gla-OMe in the 
presence of guanidine. Peptide  samples (2 mM) were lyophilized 
from  ammonium bicarbonate buffer (0.1 M) containing various con- 
centrations of guanidine,  sealed, and heated in U ~ C U O  at 110 ‘C  for 1 
h. Percent Gla remaining is presented as a function of peptide/ 
guanidine ratio present prior to lyophilization. 
different concentrations. The latter is essential since each 
data  set  must  be  represented by the  same  set of equilibrium 
constants.’ 
An initial  assumption  in  the  metal  ion  binding  simulation 
was that  all species bound  to  metal  ions were protected  from 
decarboxylation. Let P = peptide  and M = metal. Since we 
were unable to accurately describe either system [Ca(II) or 
Mg(II)]  with  the  PM,  PM2,  or  P2M  (with  the Gla  side chains 
of both  peptides  protected) models, this  assumption was ree- 
valuated. Examination of the  protection profiles (Figs. l and 
2) for the lower peptide  concentration (0.2 mM) suggests that 
the  PM  and  the  PM2 species must  be protected;  whereas, as 
the  peptide  concentration was  increased, the curves (protec- 
tion uersus metal/peptide)  take  on a  sigmoidal shape  and, for 
Ca(II),  shift o  larger metal to  peptide  ratios. A  previous paper 
(16) reported a similar sigmoidal shape in the protection 
profile of Gla in the presence of guanidine (Fig. 4). The 
sigmoidal shape for the protection of a Gla residue in the 
presence of guanidine was postulated  to be due  to  the  forma- 
tion of an unprotected species, the 1:1 Gla-guanidine (PG) 
complex, prior to  formation of the  protected 1:2 Gla-guanidine 
(PGJ complex. By analogy to  the guanidine analyses, it can 
be argued that,  in  the  presence of a low concentration of metal 
ions,  the higher peptide species (P,M, n > 1) is  either  partially 
or not at all  protected.  Therefore, a “protection coefficient” 
for  the  P2M species of the  P2M model was introduced.’ This 
expanded  PzM model provided for a better  description of all 
data sets;  the  PM  and  PM, models were not improved with 
the addition of the protection coefficient. In the case of 
Mg(II),  the  binding  constants  determined from the  data  at 
the  three  peptide  concentrations (0.2, 2.0, and 17.5 mM) were 
approximately  the same. The average  equilibrium constants 
for the  three  sets provided a good fit of the  data.  Thus, a 
model had  been  found which simulates  the Mg(I1) ion  con- 
centration profiles. Consistency of the Ca(I1) equilibrium 
constants determined for the three peptide concentrations 
with  the  P2M model was somewhat improved, although  the 
fits were still not acceptable. Clearly, Mg(I1) and Ca(I1) do 
not  bind  in  an  identical  manner  to  the malonyl group of a Gla 
residue. 
In  order  to  better describe the Ca(I1) experiments, a P3M 
Portions of this paper (including “Theoretical Modeling” and 
Tables 1 and 2) are presented in miniprint a t  the end of this paper. 
Miniprint is easily read with the aid of a standard magnifying glass. 
Full size photocopies are included in the microfilm edition of the 
Journal that is available from Waverly Press. 
species  was added  to  the  P2M model; this inclusion  (Calcula- 
tions, Section 6) provided a satisfactory simulation of the 
calcium data sets when  only one of the three malonate 
subgroups was constrained  to  be  stable  to  thermal decarbox- 
ylation. The  PsM model did  not significantly enhance  the  fit 
of the Mg(I1) data.  Thus,  binding of both  metal  ions  has  been 
simulated by different models. The Mg(I1) data requires the 
inclusion of a PzM species in  addition  to  the  PM species while 
the Ca(I1) data requires a further  additional species, P3M. In 
both cases, the higher peptide (P,M, n > 1) species were not 
completely protected.  We conclude that a  discernible  differ- 
ence  in the  binding of Ca(I1) and Mg(I1) to Gla exists. Both 
metal  ions  form a 1:l complex (PM)  that is protected  from 
decarboxylation; it is reasonable that  the  structure  is a  che- 
lation  bidentate  (a form of chelation  that involves both  car- 
boxylate  groups of Gla). The difference  found  between Mg(I1) 
and Ca(I1) appears  in  the  nature of the higher peptide species 
(P,,M, n > 1). In the case of Mg(II), the P,M species is 
“unprotected” and both malonate groups are probably in a 
thermally labile unidentate or bidentate  arrangement  in 
which only one carboxylate is involved. For Ca(II), on the 
other  hand,  the  P3M species is  apparently  one-third  protected, 
with one of the malonate subgroups in a stable chelation 
bidentate type and the remaining malonate subgroups in a 
labile  geometry consistent with either a unidentate  or  biden- 
tate  orientation.  There was no evidence in  these  simulations 
that Mg(I1) forms a  P,M species. 
DISCUSSION 
Various experimental  and  theoretical  techniques have  been 
utilized in an attempt to study the complexation of Gla 
residues with metal ions. Among these methods are x-ray 
crystallography (22-30), fluorescence (31, 32), and various 
NMR  experiments (31, 33-36). These  studies have  been un- 
able  to unambiguously detect a  difference  between the  binding 
of Ca(I1) and of other  metal  ions, specifically Mg(I1). 
Thus  far,  Gla-metal  ion complexes have  not been  success- 
fully examined by x-ray crystallography (22), although the 
structures of substituted malonic  acids  have  been  determined. 
Curry et al. (23) reported the crystal structures of methyl 
malonate ion  with both Mg(I1) and Ca(I1) ions. These workers 
reported that the Mg(I1)-methyl malonate ion complex is 
strictly monomeric and  octahedral.  The  Ca(I1)-methyl  malon- 
ate  ion complex is polymeric, containing  both six and seven 
coordinate calcium ions  with  the various methyl  malonate ion 
in  all  three  types of possible ion-binding modes: unidentate, 
bidentate, and chelation bidentate. The observation that 
Ca(I1) ion-malonate ion derivative complexes can be poly- 
meric, or  are  not  strictly  octahedral,  has been  made by other 
researchers (24-26). The only other  determined  crystal  struc- 
ture for a malonate ion complexed with Mg(I1) is the bis- 
(hydroma1onato)-magnesium complex (27). This bis complex 
was found to be monomeric, with both malonate ions in a 
chelation bidentate orientation and the metal octahedrally 
coordinated. Thus, although substantial differences in the 
crystal  structures of malonate-metal  ion complexes exists,  no 
systematic  pattern for Ca(I1) and Mg(I1) ions  binding  to  the 
malonate ion emerges. 
Differentiation between the  binding of these  divalent  metal 
ions  with  substituted  malonate  ions  has l o been the subject 
of several theoretical  studies (37-42). These  calculations sug- 
gest that  either  metal ion  (Ca(I1) or Mg(I1)) will interact with 
the  malonate ion in a similar  manner, specifically, with the 
metal in  a chelation  bidentate  orientation,  although  the 
Mg(I1) ion has a  somewhat  larger  calculated  binding  energy 
for in uacuo complexes. 
CafII), MgfII)  Binding  to 
The results of the present analysis of the  thermal decar- 
boxylation data suggests that  the highly coordinated (presum- 
ably tight)  sites of the protein will bind Ca(1I) with a different 
coordination behavior than Mg(I1) binding. The binding of 
either metal ion to a single Gla residue (presumably the loose 
sites) should be similar. Thus  Ca(II), by virtue of its larger 
radius, appears to be able to bind to a greater number of 
negatively charged ligands than Mg(I1). At  low metal ion 
concentrations, Mg(I1)  may  be expected to form uni- or bi- 
dentate complexes of the P,M type, i.e. (. . . Gla . . .)zM, with 
protein Gla residues. The 2 Gla residues could  come  from the 
same protein chain, from 2 Gla residues on two different 
protein chains, or both. Ca(II), on the other  hand, may form 
PsM or even more  complex forms. 
The dissociation equilibrium constants obtained from the 
simulation of this  data  are 1 to 2 orders of magnitude tighter 
than one would expect based upon equilibrium dialysis data 
(6, 8, 9, 43,  44) performed at 25 "C. The peptide/metal solu- 
tions were frozen in a dry ice/isopropanol bath (-80 "C); 
therefore, there could be a  substantial  temperature effect on 
the thermodynamic equilibrium constants. The relationship 
of the equilibrium constants determined in this study to 
constants from an equilibrium dialysis study is not easy to 
establish; however, our results  are highly  suggestive of differ- 
ences in structure between Gla and Ca(I1) and Mg(I1) com- 
plexes. 
This study presents new data which, when added to  the 
growing list of other information (6, 9, 23, 24, 43, 44), tends 
to support the concept that calcium/magnesium ion differ- 
ences seen in biological systems may  be  due to  the relatively 
limited coordination sphere of magnesium as compared to 
calcium. 
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1362 Ca(II), Mg(II) Binding to y-Carboxyglutamic Acid 
Supplmental %rerial t o :  
DECARBOXYLATION TO PROBE m A L  I O N l C l a  INTEMCTIONS.  
STUDIES ON C a ( I I )  BINDING I O  ~ - C A R B O X Y ~ l l r h n l C  ACID. USE OF mEWI 
Michael R. Lewis, David w.  Deerfield 11, Randal li. Hoke, Karl A. 
Koehler. Lee G .  Pedernen, and Richard G. Hiskey. 
TREDRETICAL M D E I I U G  
section 1 
Theoretical modeling of the experimental data involved: 
1. choosing a particular tharnodynaaic model 
2. finding the closest match between the model and 
the experiment by Optimizing the thermodynamic 
binding constant(s1. 
3 .  comparing the 'goodness Of fit' Of this model with 
other possible models. 
The basic decarboxylation experiment con is  ed  of ten ampler 
with fixed total peptide concentration ( E .  1 = 0 . 2 ,   2 . 0 ,  or 17.5 
lanl. Sufficient metal solution  (either af iun o r  magnesium) was 
added to each peptide solution to establish a specific ratio of 
neta l  to peptide (molar ratios: 0.0, 0.125, 0 . 2 5 0 ,  0.333, 0.500. 
contained no metal ion and thus provided the amount of 
0.750.  1.0, 2.0, 4.0, and 8.01. The first experimental solution 
decarboxylatlon Of "unprotected" GLa under the reaction 
conditions (heating one hour at 110 Cl of the other nine smpies. 
The average 'blank' (experimental point one (ep(l1) gave an 
a v e r w e  of 6% decarboxylation;  this amount was not a function of 
peptide Concentration. Saturation was reached at high metal 
ion:peptide ratio (an average of 9 %  protection) and the last 
experimental point [ep(lOll was used to represent the average 
total amount Of "protaction". 
Since previous observations (16) that the 1:l complex between Gla 
and guanidine decarboxylated at the same rate as Gla itself, we 
assume thet a l l  .Unprotected" species decarboxylated at the same 
rate 11s Gla. 
Secondly,  we assume that the percentage of Gla remaining after 
heating (eq!ill is the sum of the Gla in "unprotected" and 
"protected specieai 
Eq 1-1 




This equation provides a basxs for the comparing the different 
metal forms. 
Section 2 - The PM Model 
The simpleat case for the simulation of the experimental data 
allows for a one to one complex between peptide and metal ion: 
Eq 2-1 Pf + nf - PM 
The equilibrium constant can be written as: 
E4 2-2 K1 = [Pfl*[YfI/[P~l 
Where1 
Eq 2-3 [Pfl = [ptl - [.MI 
Eq 2-4 bfl = [Mtl - [PHI 
substituting equations 2-3 and 2-4 into 2-2 leads to: 
Eq 2-5  Kl i [[P~] - [PM]I*( kt] - [..I I/@] 
expanding: 
Eq 2-6 K1*[PII]  [Pt]*[Mt] - [Pt]*[PM] - [Mt]*[PU] 
rearrangement givear 
Eq 2-7 0 F [PM]' - ([Idt] + [P,] + Kll*[Pn] + [Pt]*[Mt] 
This quadratic hae two SOlutionS: 
Eq 2-8 [PM(ll] i ~[nt]*[Pt]~Kl~~~[Pt]+[nt]*Kll2-4~[Pt]*[Mt]l0~5~/2 
Eq 2-9 [..[21] = ~[Mt]*[Pt]+Kl-~~[Pt]*[~t~*K~l2-4*[Pt]r[Mt]~o~5~/2 
&
In this model, PM is aaaumsd to be .protected". Therefore,  the 
mole traction of "protected" species is the mole fraction of the 
PM species. P is "unprotected"  and thus the mole fraction of 
"unprotected" fspecies would be the mole fraction of P,. 
The difference between the Calculated point (cp(i11 and 
experimental p i n t  (ep(i11 is aquared to give  the deviation of 
the experimental data at that given combination of 
Eq 2-11 SS = (cp[il - ep(iIl2 
The deviation io then sumed over the nmber of experimental data 
point@ and dlvided by the degrees of freedom O f  the model 
j=variablss in the modell to define a 
Eq 2-12 MSE i 1 SS / ( n  - j l  
KI was varied until the minimum MSE function was found. 
1-1 
Section 3 - The  PM2 Model 
The following sequential addition of two metal ions to L) single 
peptide residue was considered: 
Eq 3-1 Pf t nf & pn + M f  &pM2 
The equilibrium constants can be written as: 
Eq 3-2 K1 = [Pf]*[nf]/[P"] 
Eq 3-3 K2 = [PH]*[Mf]/[Pn2] 
Rearrangement leads to: 
Eq  3-4  [PM] = [Pf]*[nf]/Kl 
Eq 3-5 b2] = [Pn]*[nf]/K2 = [Pf]*[Mf]*[Mf]/~Kl*12) 
substitutin~ equat' 
balanccd equations. 
Eq 3-6 [P,] = [Pf] + [PM] + [pn2] 
Eq 3-7 [Pt] = [Pf] + [Pf]*[nf]/Kl + [.f]*[Mf]'[nf]/(Kl*X1) 
Eq 3-8 [Mt] = [Mf] + [PM] 1 2*[PM2] 
Eq 3-9 kt] = [Mf] + [Pf]*[Mf]/Kl + 2*[Pf]*[Mf]*[Mf]/(K1*K21 
Substitution of the m s s  balance equations 3-7 and 3 - 9 .  
respectively, into the denominator of the folloring identities: 
Eq 3-10 [Pf] = [Pf]*[Pt]/[et] 
Eq 3-11 [nf] = [M~]*[M~]/[~~] 
leads to: 
Eq 3-12 [Pf] = [ P f ] * [ P t ] / ~ [ P f ~ i [ e f ] * [ n f ~ / K l * [ p f ] * [ n f ] * [ y f ] / ~ K 1 ~ K 2 ) )  
Eq 3-13 [P,] i [Pt]/(l + [Mf]/K1 f [Mf]*[Mf]/~11'K211 
and 
Eq 3-14 [Mf] = [ . f ]*[ . t ] / ( [ . f ]+[Pf] . [ . f ]h1+2' (Pf]*[Mf]*[Mf] / (Kl*K2))  
Eq 3-15 [nf] i [Mt]/(l I [Pf]/K1 + 2*[Pf]*[Mf]/(Kl*K2)l 
With the aesuned X and I a calculated point ia found [cp(ill 
and compared with $he sxp&iental point (ep(il1 to provide a 
variance (SSI for each point. These variances are rumed over the 
data set tO determine a specific MSE for eech set Of K and K . 
The values for X and K are Changed through a soquenttal ,ria 
search until thelminimu& in the MSE function Is found. 
Section 4 - The  P2u Uodel, The Use of the Protection Pactor 
The third model investigated was one in which a higher order 
peptide species was allowed to form, apeclfically P2M. The 
equation is! 
Eq 4-1 Pf Mi & PSI + Pf &PM2 
In a ma ner a'mil z to that Outlined in SBE io 3 t e equstions 
'3. 
for [PM! and tP2My are written in terms of lPff, [ M f r ,  K l ,  and 
Eq 4 - 2  [PR] = [Pf]*[lf]/Kl 
Eq 4-3 [P2M] = [Pf]*[Pt]*[Mf]/(Kl*K31 
Then, into the w 8 s  balanced equations: 
Eq 4-4 kt] - [pf] + [PHI + [pn2] 
Eq 4-5 [ut] = [Mf] + [PU] + 2*[PM2] 
were aubstltuted equations 4-2 and 4-3. the resulting maSS 
balanced equations were then substituted into the idsntitiaa 3-10 
and 3-11 to yield: 
Eq 4-6 [Pi] i [Pt]/(l + [nf]/Kl f 2*[Pf]*[nf]/[Kl*K3l1 
Eq 4-7 [Mf] i [M,]/(l f [Pf]/Kl f [Pf]*[Pf]/(Kl*K3)l 
Equationa 4-6 a d 
Section 61 and PM and P M are calculated with appropriate 
1 1-7 ;r'r s o y  by the iterative method (sea 
equations [aqua io 8 4 2 d d  4-31. It is necessary to  define 
whether each species is "protected" from therm1 decarboxylation. 
Prom previous results it was obvious that P is "unprotected" and 
that Pn ie .protected" f rom decarborylatlod. It in, however, not 
obvious whether P M would be .pxotected". Since there are tW0 
peptide residues g r  -tal ion,  the total complex cauld be 
totally "unprotected". half .protected", oc totally "protected". 
1n the simulation of the data, each of  these possibilities was 
examined and a new variable was introduced - P1. P1 has three 
possible va1u.a: 0-unprotected, 0.5-half protected, 
1.O-pmtected.  Therefore,  the equation for the protected SPeciOB 
is modified to: 
Eq 4-8 ["Protected"] i (2*P1*[P2M] + [Pn])/[Pt] 
If  ~1 represents the amount "protected", then (l-Pl) represent8 
equation yieldar 
the amount "unprotected". Modification of the unprotected BPeCieS 
Eq 4-9 ["Unprotected"] i (2*(l-P11*[P2M] + [Pf]l/[Pt] 
Substituting equations 4-8 and 4-9 into equation 1-1 leads to: 
Ca(II), Mg(II)  Binding to y-Carboxyglutamic Acid 
K  and  K were systematically  varied  through a grid  search  until 
tie mini,&m USE value was found. 
Section 5 - The P p  Model 
Eq 5-1 Pf + U PM t Pf  M2 * Pf - P3U 
into  the mass balance  equation: 
Eq 5-2 [Pt] = [P,] + [..I + 2*[P2u] + 3*[P1M] 
one substituted  the  appropriate  equations  (equations  4-2  and  4-31  and: 
E4 5-3 [P,,U] = [Pf] [Pi] [Pf] [nf] /(Kl*K3*K41 
to give: 
Eq 5-4 k t ]  = [.fl + [:f~;lprt.':~.~p:jre~~j~~~~:~~~~~K1*K3) + 
Substituting  equation 5-4 into  the  denominator of equation 3-10 and 
then  simplifying  yield5: 
Eq 5-5 kt] = [.,I 
In a similar  manner,  equation 5-6 is  found: 
Eq 5-6 [M,] = [Mtl 
It vas found  that 
itersit've aetho ( S~~~i~fl]'::f,~~::t~~~~u~~ted with 
4fte IP ]w;;: found. one then  calculates TP;?:' IiZi], 
and IP3Ul tiona 4-2. 4-3, and 5-3. 
It  is  assnmed  that PM is "protected"  and P is "unprotected": it 
P M. As before  (Section 5 )  P U could  either  be  "unproteked" 
is  necessary  to  evaluate the -unt of  "prdtection"  for P M and 
(?1=0).  half  "protected" (dl=d.51, or totally  "protected"  [Flell. 
There ore the  contribution  for  P M to  the  "protected" (I CL s IS 
2*P1*[P2M] and  to  the 'UnprOteCte%" Species is 2*(l-Fl)*v2Mr. ' 




Svbrtitvtinq  the  appropriate  terms  into  equation  1-1  leads to: 
Eq 5-6 cp(il = ep(l)*([Pf]+2~F1*[P2M]+3*F2*[P3M])/[Pt] 1 
ep(101*([Pn]+2~(l-F1)*[P2M]+3*~l-P2)~[P3n])/[Pt] 
Thus, for any combination of K K and X it is necessary to 
also evaluate  the  12 differentl~omajnationdlof F1  and  F2 (P1= 0, 
Calculated  points.  thus  twelve  different  variances.  Theme 
1/2. 1; P2= 0, 1/3. 2/3. 11, which  results  in  twelve  different 
variances are s u m e d  over the  data set. The W E  error is 
calculated  and  the  minimum  io  found  by  systematically  varying  Kl, 
K3,  and K1 in a seqnential  grid seamh. 
Section 6 - Different  nethods  for  Calculating [Pf] and [nf] 
There are at  least  three  different  ways  to solve equations 3-13 
and 3-15. 
Eq 3-13 Ff] = [pt]/(l + [nf]/K, + [Uf]*[Uf]/[X,*K21~ 
Eq 3-15 [nf] = [Ut]/(l + [Pf]/Kl + 2*[Pf]*[n~]/(Kl'K211 
Section 6.A - Analytical  nethod 
TM,] derived as follows: 
E4 6-1 [Uf] = [U,]/[l + [Pf]*(l/K1 + 2*[nf]/(Kl*K2111 
and  then  substitution  Of 3-13 into 6-1 leads  to: 
Eq 6-2 ~ ~ ~ ~ ~ ~ ~ ~ ~ ~ f ] / ~ K l * K 2 l l * ~ [ P t ] / ~ l f [ U f ] * ~ l / K l + [ U f ] / ~ K l * K 2 l l ~  
Expanding  and  rearranging  leads to: 
Eq 6- 
he  first  method  involves  the  analytical  Solution Of a polynomial in 
~Uf]3+(K2+2~[et]-[nt])~[nf]2*K2*~K1+[Pt]-[Ut]l*[Mf]-Kl*K2*[Ut]=0 
Equation 6-3 is in the  cubic  form  of  y3 + py2 + qy * r ,  where: 
Eq 6-4 P = K2 * 2*[Pt] - kt] 
Eq 6 - 5  q = K2*(Kl * [et] - [.,]I 
Eq 6-6 c i K1*K2*[ntl 
this is thio  converted  to  the  form of x3 + ax + b = 0. where: 
Eq 6-7 y i x-p/3 
Eq 6-8 a i (3.q - p21/3 
Eq  6-9  b = (2.p' - 9.p.q + 27*r)/27 
In general, there are three  solutions  for  this  equation: 
Eq  6-10 [Mf(l)] i 2*[[-~/311'21*=~~1~/31 - p13 
Eq 6-11 [nf(2)] = 2.1(-a/311/2)*co.(o/3 * 2*m/3) - p/3 
Eq 6-12 [Mf(31] i 2 * ( ~ - ~ / 3 1 1 ~ 2 1 * ~ ~ ~ ~ ~ / 3  * 4**/31 - p/3 
where: 
Eq 6-13 R = ~===~~([-b/2]*((-~3/27)1/2]] 
There are several  difficulties  with  this  method:  The  first  problem 
i9 the  obvious  necessity  of  deciding  rhic r Ot  [Eq 6-1 
5-12]  is  within  the  reasonable  limits of )U 1 (i.e. 0<]iff&]7: 
Even within a series  of  calcuiations,  the r6 mnabl: ro t 
change.  Another  problem concerns the  evaluation  of  the arc cosine 
function. Most  micro-computers  do not evaluate arccos(x1: but 
instead. one must  Convert  into an arc-tan(y1 (at") function: 
Although  for a l l  values Of X. arccon(x) is defined,  arctan is not 
trapping  in  the  computercode  is  necessary.  The  code  necessary  for 
(when x=l, the  denominator is equal to 01. Consequently, error 
This  leads  to  both  programing difficulties and  increased 
a program "sing the  analytical  method  is,  at  beat,  Cumbersome. 
computational time. Solving  the  analytical  polynonlala for more 
complex  thermodynamic  equilibrium  equations is impractical. 
Section 6.8 Newton's  Method 
The  second  solution  utilizes Newton's iterative  method  of  swcesive 
apprOXimati0"S: 
Eq  6-15 [nf](i+ll i [.f](il - P(i)/P'[i) 
where P(i1 is a functio;(yf :f . When a solution is found. 
F(i1-0. In this case, I &"a1 to equation 6-3. that is: 
P'(i1 is  the  first  derivative of P[il 
Eq 6-17 F'[il = 3'[Mf]2+2*~K2+2~[Pt]-[Ut]l*[1f]+K2~~K1+[Pt]-[nt]~ 
i\n inital is quessed, equations 6-16 and 6-17 are evaluated 
and  he  t e61 values a r  u ed in equation  6-16  to  CaICUlate a ;;; /;[I, 1" lWf om 6-15,  equations  6-16 and 6-17 
a co ,,~,, kfl i? c?lculated. This pcocess is 
c nt'oued u ti 
('U [x+ll-'M (ill/ M <0.0011. The advantaqe of this method is 
tAaE'the prc4gbimin~ib'simple  and  the  calculations are  
always  converge, but will  occassianally lead to  Oscillations, 2.1 
relatively fast. The disadvantages  are, 1.1 This method  does not 
]:61 ti.=. O <  M I ,  or 3 . 1  the convergent Solution may 
to the  reasonable  limits (See Section  6.Al. 
Section 6.C The  Iterative  method 
We have  found  the  moot  reliable  procedure  to  be an iterative 
method  that  sinultanoQualy solyes.equationr 3-13 and 3-15. 
e r l a  IS met  (e.g., 
he  converqent Bo Y io may not be  within  reasonable  limits Of 
nd upob  thd & k k d i q  point if there are multiple  roots close 
Initial  estimates  of [ ~ g ] j a ; ~ d l ~ ~ ~ l ~ ;  used to (Itart the 
and 3-15, and  used  in 
iterative  cycle. New next evalueo are  obtained from 3-13 
criterion is used. The  essential  code  (in  BASIC) is: 
Eq 6-18 FOR I=1 TO 100 
Eq 6-19  PP i PT/(1 + UF/Kl + UF*UP/Kl/K2) 
Eq  6-20  MF i UT/(l + PF/Kl * 2*PF*UP/Kl/12) 
Eq  6-22 
Eq 6-21  IF A8S~ -PMF/MF)<O.OOl  THEN  I= OO 
PUPrUF 
Eq 6-23 NEXT I 
The  advantage8 are: 1.1 reqardless of the  complexity Of the 
or starting  point  in  the  calculation. the value9 of bp ] and7;:f 
converge rapidly, 2.1 the  solution  is always I real nd 
computer  code is simple and  the  equations for larger models are 
reasonable  number  within  the  approprlate  boundaries, 3.) the 
easily  developed.  Therefore,  this  iterative  method was used  in 
a11 calculations, exce t  for  the  PM  model. (POT a strnllsr 
procedure, see ref 43.7 
Again, a convergence 
Resulta of Curve Fitting  analysis for Thermal  Decarboxylation of 
~-CarboxyqlutamiC  Acid in the  presence  Of CaIIIl 
(All equilibrium  EOnstantS are dissociation  constant8 (MI] 
USE ia defined  in  the  text.  The average data set's equilibrium 
conetants are the average of the  three  data  seta  equillbrium 
constants.  The MSE Ave. is  the  deviation  Of  each  data  set  when 
TABLE 1 
the  averaged  equilibrium  conatants are used. 
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Results  of  Curve  Fitting  Analysis  for  Thermal  Decarboxylation  of 
TABLE 2 
( A 1 1  equilibrium  conatants are dissociation  conatants (MI) 
I-Carboxyglut*mlC  Acid  in  the  presence of Mg(II1 
MSE is  defined in the  text.  The average data set'. equilibrium 
constants are the average Of the  three  data  sets  equilibrium 
constanta.  The USE Ave. is  the  deviation  of  each  data  set  when 
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